Anonymous
Guest
Anonymous
Guest
This is a very compelling argument for AstraZeneca remaining an independent company:
http://dealbook.nytimes.com/2014/05...hp=true&_type=blogs&partner=yahoofinance&_r=0
http://dealbook.nytimes.com/2014/05...hp=true&_type=blogs&partner=yahoofinance&_r=0